NFKB1 and atherosclerosis: Deficiency of serine palmitoyltransferase subunit 2, a key enzyme involved in the ceramide de novo synthesis pathway, could reduce murine atherosclerosis partly by attenuating TLR4 recruitment and downstream NF-κB-mediated inflammation (25).